Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.5B |
| 2 |
Apple
AAPL
|
+$1.68B |
| 3 |
Tesla
TSLA
|
+$951M |
| 4 |
Johnson & Johnson
JNJ
|
+$750M |
| 5 |
UnitedHealth
UNH
|
+$703M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTXS
Citrix Systems Inc
CTXS
|
+$913M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$257M |
| 3 |
NVIDIA
NVDA
|
+$225M |
| 4 |
Vertiv
VRT
|
+$164M |
| 5 |
JPMorgan Chase
JPM
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.48% |
| 2 | Healthcare | 7.36% |
| 3 | Financials | 6.5% |
| 4 | Consumer Discretionary | 5.35% |
| 5 | Industrials | 3.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3376
B&G Foods
BGS
$287M
| $384K | ﹤0.01% |
34,418
+13,915
| +68% | +$194K |
|
3377
Aura Biosciences
AURA
$735M
| $383K | ﹤0.01% |
36,519
-5,525
| -13% | -$70.3K |
|
|
ROCC
3378
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
| $382K | ﹤0.01% |
9,457
-1,677
| -15% | -$66.4K |
|
3379
American Well
AMWL
$170M
| $381K | ﹤0.01% |
6,733
+2,556
| +61% | +$184K |
|
|
KAMN
3380
DELISTED
Kaman Corp
KAMN
| $380K | ﹤0.01% |
17,061
+9,683
| +131% | +$234K |
|
3381
Acushnet Holdings
GOLF
$6.11B
| $380K | ﹤0.01% |
8,940
+4,630
| +107% | +$209K |
|
|
MRC
3382
DELISTED
MRC Global
MRC
| $380K | ﹤0.01% |
32,773
+10,082
| +44% | +$106K |
|
|
ACRE
3383
Ares Commercial Real Estate
ACRE
$259M
| $379K | ﹤0.01% |
36,879
+34,702
| +1,594% | +$399K |
|
|
BELFB
3384
Bel Fuse Inc Class B
BELFB
$4.17B
| $378K | ﹤0.01% |
11,489
-1,775
| -13% | -$58K |
|
|
TIGR
3385
UP Fintech Holding
TIGR
$863M
| $378K | ﹤0.01% |
110,776
| – | – |
|
3386
ADT
ADT
$5.66B
| $378K | ﹤0.01% |
41,646
-119,734
| -74% | -$1.06M |
|
3387
Shenandoah Telecom
SHEN
$717M
| $378K | ﹤0.01% |
23,782
+10,873
| +84% | +$199K |
|
3388
Magnite
MGNI
$2.93B
| $376K | ﹤0.01% |
35,538
+262
| +0.7% | +$2.39K |
|
|
KKR.PRC
3389
DELISTED
KKR & Co. Inc. 6.00% Series C Mandatory Convertible Preferred Stock
KKR.PRC
| $375K | ﹤0.01% |
+6,552
| New | +$395K |
|
3390
James River Group Holdings
JRVR
$214M
| $375K | ﹤0.01% |
17,932
+8,006
| +81% | +$184K |
|
3391
Surgery Partners
SGRY
$2.03B
| $374K | ﹤0.01% |
13,436
+735
| +6% | +$19.5K |
|
3392
RB Global
RBA
$20.8B
| $373K | ﹤0.01% |
6,444
-653
| -9% | -$38K |
|
3393
SandRidge Energy
SD
$497M
| $372K | ﹤0.01% |
21,858
+5,660
| +35% | +$106K |
|
3394
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$19.8B
| $372K | ﹤0.01% |
2,070
+1,400
| +209% | +$254K |
|
3395
Uranium Energy
UEC
$5.12B
| $371K | ﹤0.01% |
95,586
+81,292
| +569% | +$309K |
|
3396
Metallus
MTUS
$855M
| $371K | ﹤0.01% |
20,395
-24,400
| -54% | -$433K |
|
|
RWT
3397
Redwood Trust
RWT
$577M
| $370K | ﹤0.01% |
54,798
+11,028
| +25% | +$77K |
|
3398
Nektar Therapeutics
NKTR
$2.44B
| $370K | ﹤0.01% |
10,927
+1,297
| +13% | +$62.8K |
|
3399
Mercury Systems
MRCY
$6.62B
| $370K | ﹤0.01% |
8,265
-4,845
| -37% | -$229K |
|
3400
Tevogen Inc. Common Stock
TVGN
$29.6M
| $369K | ﹤0.01% |
714
-3,000
| -81% | -$1.54M |
|
Similar funds
Barclays's Q4 2022 Portfolio in Review
As of Q4 2022, Barclays held 5,646 positions worth $223B, up 144% from $91.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $128B of net new capital in Q4 2022, opening 798 new positions and adding to 2,634 existing holdings. Its largest new stake was Seadrill: 1,546,558 shares worth $50.5M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $257M trimmed.
- Barclays's largest Q4 2022 buy was Seadrill: 1,546,558 shares worth $50.5M.
- Barclays added most to Microsoft in Q4 2022, an estimated $2.5B increase.
- Barclays's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $257M.
- Barclays fully exited Citrix Systems Inc in Q4 2022, selling an estimated $913M.
- Barclays's ten largest holdings make up 41% of its $223B portfolio in Q4 2022.
- Barclays opened 798 new positions and closed 385 in Q4 2022.
- Barclays's portfolio value rose 144% quarter-over-quarter to $223B.
Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.